Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HRH1 | P35367 | 2/20 | 0.37 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.37 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.37 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6956036 | 0.85 | TRPA1 (0.52) | TAAR1TRPA1ALDH1A1HRH1CACNA1F | |
| SCHEMBL8124007 | 0.83 | TRPA1 (0.39) | TAAR1TRPA1ALDH1A1LMNAHRH1 | |
| SCHEMBL3031215 | 0.81 | TAAR1 (0.43) | TAAR1LMNAHRH1CYP3A4ALOX15 | |
| SCHEMBL8113459 | 0.80 | TRPA1 (0.37) | TAAR1TRPA1ALDH1A1LMNAHRH1 | |
| SCHEMBL1774828 | 0.80 | LMNA (0.46) | TAAR1TRPA1ALDH1A1LMNAHRH1 | |
| SCHEMBL872695 | 0.78 | TRPA1 (0.53) | TAAR1TRPA1ALDH1A1LMNAAOC3 | |
| SCHEMBL8558578 | 0.78 | ALDH1A1 (0.46) | TAAR1TRPA1ALDH1A1LMNAHRH1 | |
| SCHEMBL19090082 | 0.78 | TAAR1 (0.56) | TAAR1TRPA1HRH1SLC6A3AOC3 | |
| SCHEMBL2086299 | 0.78 | TAAR1 (0.56) | TAAR1TRPA1HRH1SLC6A3AOC3 | |
| SCHEMBL19294780 | 0.78 | TAAR1 (0.56) | TAAR1TRPA1HRH1SLC6A3AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0519353-B1 | Indolizin derivatives, process for their preparation and pharmaceutical composition containing them | FUJISAWA PHARMACEUTICAL CO (JP) | 2000-08-16 | — | — | EP | claimed |
| CN-1042226-C | Heterocyclic derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1999-02-24 | — | — | CN | claimed |
| US-5334716-A | Preventing testosteron 5a-reductase mediated diseases; alopecia, acne, prostatism | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-08-02 | — | — | US | claimed |
| CN-1067893-A | Hete rocyclic derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1993-01-13 | — | — | CN | claimed |
| EP-0519353-A2 | Indolizin derivatives, process for their preparation and pharmaceutical composition containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-12-23 | — | — | EP | claimed |
| US-20230094176-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENT AB (SE) | 2023-03-30 | — | — | US | disclosed |
| CN-110437046-B | Fluorine atom-containing polymer and field of use thereof | 日产化学工业株式会社 | 2022-08-16 | — | — | CN | disclosed |
| WO-2021154976-A1 | METHODS OF TREATING BRAIN CANCER WITH PANOBINOSTAT | SECURA BIO, INC. (US) | 2021-08-05 | — | — | WO | disclosed |
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENTIFIC AB (SE) | 2021-03-04 | — | — | US | disclosed |
| CN-107406584-B | Fluorine atom-containing polymer and field of use thereof | 日产化学工业株式会社 | 2020-06-09 | — | — | CN | disclosed |
| CN-110437046-A | Polymer containing fluorine atom and its utilize technical field | NISSAN CHEMICAL IND LTD | 2019-11-12 | — | — | CN | disclosed |
| US-20180030200-A1 | FLUORINE ATOM-CONTAINING POLYMER AND USE OF SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-0458207-B1 | Indole derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1997-03-26 | — | — | EP | disclosed |
| EP-0620818-A1 | ARYL KETONES AS TESTOSTERONE 5$g(a)-REDUCTASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-10-26 | — | — | EP | disclosed |
| EP-0600084-A1 | INDOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-08 | — | — | EP | disclosed |
| US-5312829-A | Testosterone 5alpha-reductase inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-05-17 | — | — | US | disclosed |
| WO-1993013099-A1 | ARYL KETONES AS TESTOSTERONE 5α-REDUCTASE INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-08 | — | — | WO | disclosed |
| US-5212320-A | Enzyme inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-05-18 | — | — | US | disclosed |
| WO-1993003012-A1 | INDOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-18 | — | — | WO | disclosed |
| EP-0458207-A2 | Indole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-11-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030200-A1 | FLUORINE ATOM-CONTAINING POLYMER AND USE OF SAME | AFF2, AFF1, AFF4 | TAAR1 2400/4885TRPA1 3711/4885ALDH1A1 2629/4885 |
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC1, HDAC2 | TAAR1 4681/4885TRPA1 4150/4885ALDH1A1 3068/4885 |
| US-20230094176-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC2, HDAC1 | TAAR1 4738/4885TRPA1 4321/4885ALDH1A1 2984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.